Market opportunity Target chemical manufacturing and specialty labs that require silica-based solid phase extraction, offering high-quality bonded phases and related consumables such as columns, plates, and GC liners to leverage UCT's established product range.

Cannabis testing niche Leverage UCT's existing cannabis industry products for pesticide and purity testing to pursue labs and contract testing organizations expanding into regulated cannabis analytics.

Growth potential capitalize on UCT’s mid‑size organization (51–200 employees) with a diversified product line and recent expansion history to upsell integrated SPE solutions, enzymes, and HPLC columns to existing customers seeking end‑to‑end workflows.

Global readiness Position UCT as a partner for specialized silica-based technologies in university, government, and pharmaceutical supply chains that value controlled processes and in‑house silane manufacturing capabilities.

Service differentiation Emphasize the strong sales and technical support heritage to win sign‑offs in highly technical purchasing cycles, offering training, integration support, and rapid spare parts to reduce downtime for customers.